XML 68 R47.htm IDEA: XBRL DOCUMENT v3.22.0.1
Common Stock - Additional Information (Detail)
 1 Months Ended 9 Months Ended 12 Months Ended 169 Months Ended
Sep. 30, 2021
USD ($)
$ / shares
shares
Jul. 31, 2021
USD ($)
Apr. 30, 2021
USD ($)
$ / shares
shares
Jun. 30, 2019
USD ($)
$ / shares
shares
Dec. 31, 2021
shares
Dec. 31, 2021
USD ($)
Vote
shares
Dec. 31, 2021
USD ($)
shares
Class Of Stock [Line Items]              
Number of votes entitled to each share of common stock | Vote           1  
Cash dividends | $             $ 0
Proceeds from issuance of common stock, net of issuance costs | $           $ 81,042,000  
Underwritten Public Offering              
Class Of Stock [Line Items]              
Sale of common stock, shares | shares 17,250,000   11,500,000        
Proceeds from issuance of common stock, net of issuance costs | $ $ 48,400,000   $ 32,600,000        
Sale of stock, price per share | $ / shares $ 3.00   $ 3.00        
Common Stock              
Class Of Stock [Line Items]              
Sale of common stock, shares | shares           28,750,000  
Ginkgo Bioworks, Inc.              
Class Of Stock [Line Items]              
Sale of stock, price per share | $ / shares       $ 9.00      
Proceeds, net of issuance costs, from issuance of common stock and pre-funded warrants | $       $ 79,900,000      
Proceeds from issuance of common stock, net of issuance costs | $       $ 57,000,000.0      
Ginkgo Bioworks, Inc. | Common Stock              
Class Of Stock [Line Items]              
Sale of common stock, shares | shares       6,340,771      
Ginkgo Bioworks, Inc. | Pre-Funded Warrants              
Class Of Stock [Line Items]              
Warrants to purchase shares of common stock | shares       2,548,117      
Warrants exercise price per share | $ / shares       $ 9.00      
Warrants exercise price per share paid at closing of offering | $ / shares       $ 8.99      
Proceeds from sale of pre-funded warrants, net of issuance costs | $       $ 22,900,000      
Warrants exercised | shares         0 0 0
Ginkgo Bioworks, Inc. | Pre-Funded Warrants | Maximum              
Class Of Stock [Line Items]              
Warrants to purchase shares of common stock | shares       2,548,117      
Unbeneficial percentage of ownership after exercise of common stock outstanding effect to issuance       19.99%      
Cowen and Company, LLC | ATM              
Class Of Stock [Line Items]              
Sale of common stock, shares | shares         0 2,447,211  
Proceeds from issuance of common stock, net of issuance costs | $           $ 8,000,000.0  
Jefferies, LLC | ATM              
Class Of Stock [Line Items]              
Sale of common stock, shares | shares           0  
Proceeds from issuance of common stock, net of issuance costs | $   $ 50,000,000.0